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ARTICLE
Epigenetic control of IL-23 expression in
keratinocytes is important for chronic skin
inﬂammation
Hui Li1,2, Qi Yao1,2,11, Alberto Garcia Mariscal1,2, Xudong Wu2,3, Justus Hülse1,2, Esben Pedersen1,2,
Kristian Helin 2,3, Ari Waisman 4, Caroline Vinkel5,6, Simon Francis Thomsen5,6, Alexandra Avgustinova7,8,
Salvador Aznar Benitah 7,8, Paola Lovato9, Hanne Norsgaard9, Mette Sidsel Mortensen9, Lone Veng9,
Björn Rozell10 & Cord Brakebusch1,2
The chronic skin inﬂammation psoriasis is crucially dependent on the IL-23/IL-17 cytokine
axis. Although IL-23 is expressed by psoriatic keratinocytes and immune cells, only the
immune cell-derived IL-23 is believed to be disease relevant. Here we use a genetic mouse
model to show that keratinocyte-produced IL-23 is sufﬁcient to cause a chronic skin
inﬂammation with an IL-17 proﬁle. Furthermore, we reveal a cell-autonomous nuclear func-
tion for the actin polymerizing molecule N-WASP, which controls IL-23 expression in kera-
tinocytes by regulating the degradation of the histone methyltransferases G9a and GLP, and
H3K9 dimethylation of the IL-23 promoter. This mechanism mediates the induction of IL-23
by TNF, a known inducer of IL-23 in psoriasis. Finally, in keratinocytes of psoriatic lesions a
decrease in H3K9 dimethylation correlates with increased IL-23 expression, suggesting
relevance for disease. Taken together, our data describe a molecular pathway where
epigenetic regulation of keratinocytes can contribute to chronic skin inﬂammation.
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Aberrant cytokine expression is believed to be crucial forthe development of inﬂammatory skin diseases such aspsoriasis1. Although the cause of psoriasis is unknown,
development and maintenance of the disease occurs through the
crosstalk between immune cells and keratinocytes. In particular,
the interleukin (IL)-23/IL-17 axis and the tumor necrosis factor
(TNF) pathway are of central importance in psoriasis as
demonstrated by successful therapeutic intervention against these
cytokines2,3. IL-23 is moreover increased in the skin of patients
suffering from atopic dermatitis (AD) or alopecia areata4 and in
the serum of patients with autoimmune diseases as systemic lupus
erythematosus (SLE)5 or Crohn’s disease6.
IL-23 is required for the development and expansion of IL-17-
producing immune cells, but the mechanism underlying the
increased expression of IL-23 is less clear. Expression of IL-23 is
regulated by nuclear factor (NF)-κB signaling, which is activated
by many cytokines including TNF7. TNF and IL-23 are produced
by activated innate immune cells, but also by psoriatic keratino-
cytes8,9, which may contribute to the development of the disease.
We now provide evidence that an epigenetic mechanism invol-
ving TNF and the neural Wiskott-Aldrich syndrome protein
(N-WASP) controls IL-23 expression in keratinocytes.
N-WASP is a ubiquitously expressed member of the WASP/
Scar family, which promotes actin polymerization via the Arp2/3
complex10,11. In vitro data indicate a role for N-WASP in the
formation of ﬁlopodia, the assembly of intercellular junctions,
and clathrin-mediated endocytosis12–15. In addition to these
cytoplasmic functions, N-WASP might also have a nuclear role,
since it was reported to shuttle between the nucleus and the
cytoplasm and to bind to a nuclear complex containing actin and
RNA polymerase II16.
Genetic ablation of the N-WASP gene leads to early embryonic
lethality in mice; however, ﬁlopodia formation is intact17.
Keratinocyte-restricted deletion of the N-WASP gene revealed an
important function for N-WASP in the control of the hair cycle,
corresponding to increased transforming growth factor-β (TGFβ)
signaling and reduction of hair follicle stem cells18,19.
Closer investigation of the interaction between N-WASP
function in keratinocytes and the immune system revealed now
that loss of N-WASP in keratinocytes provokes IL-23 expression
in keratinocytes and a chronic skin inﬂammation with an IL-17
proﬁle. Furthermore, we observed increased amounts of auto-
reactive antibodies in the serum. In vitro studies revealed that
both TNF and N-WASP are regulating IL-23 expression by con-
trolling H3K9 methylation via modulating protein degradation of
the H3K9 methyltransferases G9a and GLP. These data suggest
that keratinocytes might contribute to initiation or progression of
inﬂammatory skin diseases such as psoriasis by producing IL-23
and reveal an unexpected nuclear function of N-WASP in
epigenetic repression of IL-23, which is regulated by TNF.
Results
N-WASP ko in keratinocytes causes chronic skin inﬂamma-
tion. Mice with a keratinocyte-restricted deletion of the N-WASP
gene (N-WASP ﬂ/ﬂ K5 cre; called ko) show increased TGFβ
signaling in the epidermis, suggesting the possibility of a local
inﬂammatory reaction18. To investigate in more detail a potential
inﬂammatory response in N-WASP ko mice, we performed full
necropsies of 8–26-week-old control and N-WASP ko mice and
analyzed tissue sections by hematoxylin–eosin (H&E) staining.
Skin sections from back, tail, eye lid ear, nose, and facial skin of
ko mice of all ages indicated slight to moderate hyperplasia of the
epidermis and increased cellularity of the dermis consisting of
mast cells, granulocytes, and other mostly non-lymphoid cells
(Fig. 1a). Staining of back skin for mast cells conﬁrmed increased
number of mast cells in N-WASP ko mice (Fig. 1g). This
phenotype was particularly prominent in mechanically stressed
tissues such as tail, lip, and ear, suggesting that N-WASP-null skin
is oversensitive to mechanical stress. Macroscopically, the tails of
older N-WASP mutant mice appeared often scaly (Fig. 1b) and
mechanically stressed tissues of older mutant mice showed
occasionally focal ulcerations.
Testing proliferation of interfollicular keratinocytes in N-
WASP ko mice in an earlier study with only few mice, we had
observed a high variation in proliferation and could not detect a
signiﬁcant change18. Repeating the proliferation measurement by
testing for Ki67+ cells using more mice and more samples, we
now show that proliferation in N-WASP ko epidermis is indeed
normal in 6- and 9-day-old mice, but increased at 3 and 7 weeks
compared to littermate controls (Fig. 1d). These data indicate that
N-WASP ko mice develop a skin hyperplasia after birth.
K6, which is often upregulated in hyperproliferation, was not
detectable in interfollicular keratinocytes of 6-day-old N-WASP
ko mice, conﬁrming the absence of hyperplasia in very young
mice. However, in 9-day-old N-WASP ko mice, rare, focal
upregulation of K6 expression was observed in the interfollicular
epidermis, which then became more widespread in older mice
(Fig. 1c). In our earlier analysis, no interfollicular K6 was
detectable in 9-day-old N-WASP ko mice18. The reason for this
difference is not clear, but might be inﬂuenced by differences in
the genetic background of the outbred mice used for the analysis
and by a different animal house environment.
Next, we analyzed whether the increased cellularity of the
dermis in ko mice is due to an increased number of immune cells
by staining for the pan-leukocyte marker CD45 (Ly-5.2). While
we could see no difference in the frequency of Ly-5.2+ cells in
skin of 6-day-old control and ko mice, N-WASP ko skin showed
increased numbers of CD45+ cells at 9 days and later indicating
the presence of an leukocyte inﬁltrate (Fig. 1e). Fluorescence-
activated cell sorting (FACS) analysis conﬁrmed an increased
number of immune cells inﬁltrating epidermis of N-WASP ko
mice at 2 and 4 weeks (Fig. 1f).
To test whether the activation of the immune system also
includes the adaptive immune response and the production of
antibodies, we determined the deposition of immunoglobulin
G (IgG) in the skin of control and ko mice at different ages by
immunoﬂuorescent staining and western blot. The 7-week-
old N-WASP ko mice showed strongly elevated levels of IgG
by western blot of skin lysates and immunoﬂuorescent
staining of back skin sections (Fig. 2a, b). In older mice,
IgG deposits were also found in the kidney (Fig. 2b). No
increased IgG was detectable in the skin of 3-week-old ko
mice (Fig. 2a).
Next, we investigated whether inﬂammatory changes could
also be observed in other tissues than skin. Skin-draining inguinal
lymph nodes were increased in size in 8-week-old N-WASP ko
mice and showed signiﬁcantly increased cellularity (Fig. 2c).
Furthermore, about 20% of the ko mice older than 4 months
developed a mostly unilateral kidney hydronephrosis,
corresponding to an inﬂammation of the ureter, which might
lead to occlusions preventing the transport of urine from the
kidney to the bladder (Fig. 2d, e). Since K5 is also expressed in
ureter epithelium, K5−cre-driven deletion of the N-WASP gene
might also take place in ureter epithelium and mediate
inﬂammation.
Finally, we screened serum samples (1:100) for antibodies
against mouse keratinocytes. Of the 8 ko mice tested, all showed
clear presence of self-reactive antibodies against nuclear (4 of 8)
or cytoplasmic (4 of 8) antigens. No or clearly weaker
autoreactivity was detected at this dilution in the sera of control
mice (Fig. 2f). Further analysis of sera with antibodies against
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nuclear antigens revealed increased concentration of antibodies
against double-stranded DNA (dsDNA) in serum samples of N-
WASP ko mice (Fig. 2g).
These data indicate that loss of N-WASP in keratinocytes
results in chronic skin inﬂammation together with hyperplasia of
the epidermis, increased expression of K6, and increased
proliferation. Additionally, increased amounts of self-reactive
antibodies are observed in serum of aged N-WASP ko mice.
Increased cytokine expression in N-WASP-null back skin.
Chemokines, cytokines, and growth factors are soluble mediators
involved in the activation of immune cells. We therefore analyzed
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Fig. 1 Chronic skin inﬂammation in mice with a keratinocyte-restricted deletion of N-WASP. a H&E-stained back, tail, and perioral skin sections of 7-week-
old mice (n: 6/6). Arrows indicate increased dermal cellularity. b Representative image of tails of 4-month (4m)-old control and ko mice. c K6
immunoﬂuorescence of back skin section of at indicated ages (n: 4/4, mean ± SD, two-tailed unpaired t-test). d Quantiﬁcation of Ki67+ cells in back skin
epidermis sections (n: 4/4, mean ± SD, two-tailed unpaired t-test). e CD45 immunoﬂuorescence of back skin at the indicated ages (n: 4/4). f FACS for
CD45+ cells in back skin epidermis and quantiﬁcation (n: 3/3, mean ± SD, two-tailed unpaired t-test). g Representative toluidine blue staining for mast cells
and quantiﬁcation of mast cell inﬁltration in numbers per ﬁeld and ratio of dermal cells per ﬁeld (n: 3/3, two-tailed unpaired t-test). Arrows indicate mast
cells. Scale bars (a, c, e, g): 100 µm (*p≤ 0.05; **p≤ 0.01; ***p≤ 0.001)
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by real-time quantitative reverse transcription-polymerase chain
reaction (qRT-PCR) the expression of 17 proinﬂammatory
mediators suggested to contribute to inﬂammatory skin diseases
such as psoriasis, atopic dermatitis, or irritant contact dermatitis
in the back skin before immune cell inﬁltration (6 days), at the
onset of immune cell inﬁltration (9 days), and when IgG is
detectable in the skin (7 weeks). The 6-day-old ko mice showed
increased expression of IL-23A, CXCL10, and CCL20 (Fig. 3a)
compared to controls. At 9 days, IL-12A, IFNγ, IL-4, IL-13, IL-
17A, IL-17F, IL-22, CCL2, and IL-1β are also upregulated (Sup-
plementary Figure 2a), while in 7-week-old ko mice all cytokines
tested including IL-1α, IL-6, IFNα, IFNβ, and TNFα are increased
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Fig. 2 N-WASP knockout keratinocytes show multi-organ inﬂammation and autoimmunity. a Immunoblot analysis of IgG deposition in back skin at
indicated ages. All normalized to GAPDH (n >= 3, mean ± SD, two-tailed unpaired t-test). b Representative immunoﬂuorescence of IgG deposition of back
skin and kidney at indicated ages (n: 3/3, mean ± SD, two-tailed unpaired t-test). Scale bar: 100 µm. c Representative image of inguinal lymph nodes (iLN)
of con and ko mouse and quantiﬁcation of cellularity of iLN at indicated ages (n: 3/3, mean ± SD, two-tailed unpaired t-test). d Representative image of
kidneys of 4-month (4m)-old control and ko mice. e Representative of H&E staining of ureter. Scale bar: 50 µm. f Representative immunoﬂuorescence
staining of serum from con and ko (n: 8/8). g Detection of anti-dsDNA antibodies in serum (1:200) by ELISA (n: 4/4; mean ± SD, two-tailed unpaired
t-test; *p≤ 0.05)
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Fig. 3 Increased cytokine expression in N-WASP-null skin. a qRT-PCR analysis of indicated genes from back skin RNA of con and ko at indicated ages (n >
= 3/3, two-tailed unpaired t-test). All normalized to GAPDH. b Representative toluidine blue staining for barrier defect in con and ko mice at indicated ages
(P: E15.5 embryos used as positive controls; 2 days (2d) n: 6/5, 6 days(6d) n: 4/5, 3 independent experiments). c Representative immunoﬂuorescence
staining and quantiﬁcation of IL-23p19 of con and ko back skin at indicated ages (n: 3/3, two-tailed paired t-test). Scale bar: 100 µm. d Representative
sorting strategy of CD45+, α6H, and α6L cells from con and ko epidermal cells and qRT-PCR analysis of IL-23A and IL-17A expression in sorted cells (n: 3/
3, mean ± SD, two-tailed unpaired t-test, 3 independent sortings). e Representative immunoblots and quantiﬁcation of indicated proteins from epidermal
lysates of 7–8-week old con and ko mice (n: 4/4, mean ± SD, two-tailed unpaired t-test). f Representative immunoblots and quantiﬁcation of indicated
proteins of co-precipitations of IL-23p19 with IL-12p40 from epidermal lysates of 7–8-week-old con and ko mice (n: 4/4, mean ± SD, two-tailed unpaired t-
test; *p≤ 0.05; **p≤ 0.01; ***p≤ 0.001)
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in the back skin compared to controls (Fig. 3a). IL-23 is a dimer
consisting of the proteins IL-23p19 (gene: IL-23A) and IL-12p40
(gene: IL-12B). Both of these subunits are increased in N-WASP
ko skin on the protein level (Fig. 3e), indicating increased
expression of IL-23 in the absence of N-WASP. Co-precipitation
of IL-23p19 with IL-12p40 demonstrated increased amounts for
IL-23 heterodimers in N-WASP ko epidermis (Fig. 3f).
To investigate whether the increased cytokine expression is
related to impaired barrier function and increased Toll-like
receptor signaling, we performed barrier assays and tested for
phosphorylation of NF-κB (pNF-κB (S536)) and pIRAK4 (T345,
S346). Dye penetration assay did not indicate impaired barrier
function in 2- or 6-day-old mice (Fig. 3b). Furthermore, no
increased phosphorylation of NF-κB or IRAK4 could be detected
in skin lysates of 6-d-old mice (Supplementary Figure 2c). These
data suggest that the increased cytokine expression is not caused
by a primary barrier defect. In 7-week-old N-WASP ko mice,
expression of involucrin, ﬁllagrin (50 ± 9.8-fold increase as
determined by qRT-PCR, n: 2/2), cystatin A, Tgm1, and a
number of small proline-rich genes and late corniﬁed envelope
genes was increased, while expression of loricrin and corneodes-
mosin was unchanged compared to controls, suggesting maybe
subtle changes of the barrier at the stage of chronic skin
inﬂammation (Supplementary Table 1).
Immunoﬂuorescent staining for IL-23p19 in back skin sections
of 6-day and 4-week-old control and ko mice conﬁrmed
expression of IL-23p19 in the epidermis of 6-day-old ko mice
in both basal and suprabasal keratinocytes with further enhanced
expression in the epidermis of 4-week-old ko mice (Fig. 3c).
These data indicate that increased expression of IL-23p19 is a
very early event in skin inﬂammation in N-WASP ko mice, which
precedes the expression of most other cytokines and immune cell
inﬁltration.
To analyze the cellular source of IL-23, epidermis of 4-week-
old control and ko mice was trypsinized and the cell suspension
stained and sorted by ﬂow cytometry into immune cells (CD45+),
basal keratinocytes (CD45− α6 integrinhigh), and suprabasal
keratinocytes (CD45- α6 integrinlow). qRT-PCR analysis revealed
that the increased amounts of IL-23A in N-WASP-null epidermis
are exclusively produced by basal and suprabasal keratinocytes
and not by immune cells (Fig. 3d). As expected, IL-17A is only
expressed by immune cells, but neither by control nor N-WASP-
null keratinocytes (Fig. 3d).
Detection of IL-12, IL-1β, mKC, and IL-17F protein at different
time points by enzyme-linked immunosorbent assay (ELISA)
analysis conﬁrmed a time-dependent increase in cytokine
expression in skin, tail, and ear of N-WASP ko mice
(Supplementary Figure 1). In addition to these data we have
previously reported that TGFβ-dependent Smad2 phosphoryla-
tion is increased in epidermis of 3-week-old N-WASP ko mice18,
suggesting that TGFβmight also contribute to the development of
skin inﬂammation. However, Smad2 phosphorylation was not
increased in 9-day-old ko mice (Supplementary Figure 2d).
These data show that N-WASP-null keratinocytes produce
innate cytokines and chemokines including IL-23 before inﬁltra-
tion of immune cells. At around 9 days of age, inﬁltrating
immune cells contribute to the production of a range of cytokines
and chemokines, reﬂecting a broad immune activation. Later,
IL-17 expression increases establishing the IL-23/IL-17 axis.
Different immune cells contribute to IL-17 in N-WASP ko
mice. Since IL-17A-producing cells are of critical importance in
psoriasis and probably also in other chronic inﬂammatory
diseases such as AD and SLE20, we wanted to conﬁrm the pro-
duction of IL-17A on the protein level and identify the cells
producing this cytokine. For this reason we tested epidermal cell
suspensions of 4-week-old mice by FACS for IL-17A-producing
leukocytes and investigated skin-draining inguinal lymph nodes
of 2- and 4-week-old control and ko mice for intracellular IL-17A
and the surface markers CD45, CD3, CD4, and γδTCR. In the
epidermis of 4-week-old ko mice, only a small percentage of the
leukocytes produced IL-17A, about 4 times more than in controls
(Fig. 4a). In skin-draining inguinal lymph nodes of 2- and 4-
week-old ko mice, frequency and absolute numbers of CD4 cells
and γδ T cells expressing IL-17A was strongly increased (Fig. 4b,
c). No signiﬁcant increase was observed in mesenteric lymph
nodes of 4-week-old mice (Fig. 4g), suggesting that the IL-17A
production is a consequence of the skin inﬂammation and not
due to a systemic defect in T-cell development. These data show
that different T-cell subsets contribute to the increased IL-17
levels in N-WASP ko mice.
Since K5 promoter-driven Cre expression might also lead to
deletion of the N-WASP gene in thymic epithelium which is
important for thymocyte selection, we determined the sizes of
thymocyte subpopulations (DN, DP, CD4SP, CD8SP) and of CD4
and CD8 T cells in spleen and bone marrow in 9-day-old N-
WASP ko and control mice. Furthermore, thymus epithelium was
histologically analyzed by H&E staining. No difference was found
between control and N-WASP ko mice in these assays (Fig. 4d–f),
making it very unlikely that altered thymocyte development is
contributing to the skin inﬂammation phenotype.
Skin inﬂammation is dependent on keratinocyte-derived IL-23.
To test whether the skin inﬂammation observed in N-WASP ko
mice is dependent on keratinocyte-derived IL-23, we generated
mice with a conditional knockout of IL-23A using CRISPR/Cas9
genome editing (Fig. 5a), and crossed them with N-WASP ko
mice. The resulting mice with a keratinocyte-restricted loss of
both N-WASP and IL-23A (dko) showed a dramatically reduced
expression of IL-23A messenger RNA (mRNA), indicating efﬁ-
cient deletion of the IL-23A gene in keratinocytes (Fig. 5d).
Importantly, inﬁltration of leukocytes, keratinocyte proliferation
(Ki67+ cells), and K6 expression were strongly reduced compared
to N-WASP ko mice (Fig. 5b, c). Interestingly, dko mice still
showed epidermal thickening and loss of hairs. The reduced
inﬂammation in dko mice correlated with a decreased expression
of IL-17A and S100A9 in skin (Fig. 5d). Average values of IL-17F,
IL-22, S100A8, CCL2, CCL20, CXCL10, and IFNγ were not altered
in dko compared to ko, while IL-12A and IL-12B were strongly
reduced. LL37, which was described to be a key factor in acti-
vating plasmacytoid dendritic cells in psoriasis21, IL-19, IL-20,
and IL-24 were even increased in dko mice.
Repeating the gene expression analysis with FACS puriﬁed
keratinocytes, we obtained similar results as for total skin for
S100A8, S100A9, CCL2, CCL20, CXCL10, IL-12B, and IL-23A
(Fig. 6a). Interestingly, average expression of IL-17F, IL-19, and
LL37 was decreased in both ko and dko keratinocytes compared
to controls, although the changes were not signiﬁcant. Low
expression of these mediators indicated that they are mainly
produced by immune cells. In keratinocytes, no expression was
detected for IL-17A, IL-22, and IFNγ.
These data demonstrate that the skin inﬂammation in N-
WASP ko mice is dependent on keratinocyte-produced IL-23.
Primary N-WASP-null keratinocytes express IL-23A in vitro.
To understand the molecular mechanism underlying the
increased IL-23A expression in N-WASP-null keratinocytes
in vivo, we tested whether IL-23A expression is also increased in
cultured keratinocytes lacking N-WASP. We therefore isolated
primary keratinocytes from 3-day-old control and ko mice,
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cultured them for 5–7 days in vitro and then analyzed by qRT-
PCR the expression of various cytokines. We observed increased
expression of IL-23A, CXCL10, and CCL2, while CCL20, TNF, IL-
1α, IL-1β, IL-6, S100A8, and CXCL5 were not increased (Fig. 6b).
Culturing primary keratinocytes under differentiating high-
calcium conditions did not change IL-23A expression in control
or N-WASP ko cells (Fig. 6c).
These data suggest that N-WASP also controls expression of
IL-23A in cultured neonatal keratinocytes. Analysis of gene
expression by microarray analysis from primary keratinocytes
isolated from 3-week-old mice18 did not reveal any additional
cytokine genes that showed a more than 1.5-fold alteration of the
average value, supporting that increased IL-23A expression by
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keratinocytes is crucial for triggering the complex inﬂammation
observed in adult N-WASP ko mice.
The establishment of an in vitro system allowed us therefore to
study the molecular mechanism underlying the increased IL-23A
expression N-WASP-null keratinocytes in a less complex model
system.
N-WASP regulates IL-23 expression by H3K9 dimethylation.
N-WASP is known to promote actin polymerization, which is
also crucial for the N-WASP-dependent regulation of RNA
polymerase II-mediated transcription16,22 and retinoic acid-
induced expression of HoxB23. For this reason we tested whe-
ther treatment of keratinocytes with the actin polymerization
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inhibitor latrunculin or the Arp2/3 inhibitor CK548 increases IL-
23A expression in these cells. However, both inhibitors strongly
reduced IL-23A expression (Fig. 6d). In addition, we determined
the amount of F-actin in primary control and N-WASP-null
keratinocytes by ﬂuorescence microscopy and FACS analysis after
staining with phalloidin–ﬂuorescein isothiocyanate (FITC).
Absence of N-WASP did not reduce the total amount of F-actin
in keratinocytes (Fig. 6e, f). Taken together, these data suggest
that loss of N-WASP is not promoting IL-23A expression by
decreased F-actin.
The N-WASP-related molecule WASP, which is only expressed
in hematopoietic cells, is interacting with epigenetic enzymes
leading to increased activity of RBBP5-dependent H3K4 methyl-
transferases and the JMJD2A demethylase and elevated gene
expression24. To test whether N-WASP regulates IL-23A expres-
sion by altering epigenetic histone marks, we treated primary
keratinocytes with different epigenetic inhibitors: BIX01294
(BIX), inhibiting the H3K9 dimethyltransferases G9a and GLP
and thus decreasing the repressive H3K9me2, HC (tranylcypro-
mine hydrochloride), which blocks the lysine demethylase LSD1
and increases particularly H3K4 methylation, IOX-1, which is an
inhibitor of several JmjC-domain containing histone demethy-
lases, and trichostatin A, a histone deacetylase inhibitor, which
increases histone acetylation.
The H3K9 methyltransferase inhibitor BIX induced IL-23A
expression in control keratinocytes, while it had only a relatively
small effect on N-WASP-deﬁcient cells (Fig. 6g; right panel shows
fold change relative to DMSO). One explanation for this low
effect of BIX on N-WASP-null cells could be that H3K9
methylation is already decreased in untreated N-WASP-
deﬁcient keratinocytes. Indeed, western blot analysis revealed
that N-WASP ko keratinocytes display 50% reduced H3K9me2
levels than control cells (Fig. 7a) Treatment with BIX reduced
H3K9me2 levels in controls by about 2-fold, while it had no
signiﬁcant inﬂuence on ko cells.
A crucial role for H3K9me2 in the regulation of IL-23A
expression in keratinocytes was supported by the result that IOX-
1 treatment, which increases H3K9me2 (Fig. 7b), strongly
reduced IL-23A expression in both control and N-WASP ko
keratinocytes (Fig. 6g). Interestingly, IOX-1-treated N-WASP ko
cells showed H3K9me2 and IL-23A levels similar to untreated
control cells.
Also, in vivo, H3K9me2 was reduced in N-WASP ko
keratinocytes as shown by western blot analysis of epidermal
lysates of 6-day-old control and mutant mice and by immuno-
ﬂuorescent staining (Fig. 7c, d).
To interfere with H3K9 methylation by a different method and
to test the role of this modiﬁcation for the regulation of IL-23A
expression in vivo, we analyzed IL-23 p19 expression in FACS
sorted, interfollicular epidermal keratinocyte stem cells of mice
with a keratinocyte-restricted deletion of the G9a gene. G9a ko
keratinocytes showed increased expression of IL-23A to a similar
extent in N-WASP ko cells (Fig. 7e).
To assess whether reduced H3K9 dimethylation is directly
affecting the IL-23A promoter or only indirectly controlling IL-
23A expression by regulating expression of transcription factors, a
chromatin Immunoprecipitation (ChIP) analysis for different
regions of the IL-23A promoter was performed. Indeed, we could
identify an 0.3 kb region about 0.5 kb upstream of the transcrip-
tion start site of IL-23A which showed signiﬁcantly reduced
H3K9me2 in the absence of N-WASP (Fig. 7f, “B”). This
promoter region contains binding sites for IRF3, Smad3, and
ATF-2, which were found previously to be critical for IL-23A
expression25,26. Other IL-23A promoter regions tested showed no
detectable alteration in H3K9 dimethylation (Fig. 4j; “A”, “C”).
Deleting the N-WASP gene in vitro by Cre expression in ﬂ/ﬂ
primary keratinocytes decreased protein amounts of G9a and
H3K9me2 and increased mRNA expression of IL-23A, conﬁrm-
ing that this mechanism is cell autonomous (Fig. 7g, h).
These ﬁndings indicate that N-WASP, H3K9me2, and the
H3K9 methyltransferases G9a and GLP are crucially regulating
IL-23A expression in keratinocytes in vitro and in vivo.
N-WASP regulates protein stability of G9a and GLP. Since loss
of N-WASP had a similar effect on IL-23A expression as inhi-
bition of the H3K9 dimethylation transferases G9a and GLP, N-
WASP might regulate expression, degradation, or functional
activity of G9a and GLP. Gene expression analysis of N-WASP-
null epidermis and N-WASP-null keratinocytes by microarray,
however, did not indicate decreased mRNA level of G9a and GLP.
qRT-PCR of epidermal and primary keratinocyte RNA for G9a
and GLP conﬁrmed that the mRNA levels are not signiﬁcantly
altered in vivo and in vitro (Fig. 8a, b). We therefore checked
whether loss of N-WASP decreases G9a and GLP protein.
Western blots for G9a and GLP revealed decreased protein
levels in lysates of cultured N-WASP-null keratinocytes and
epidermal lysates of 6-day-old mice, suggesting that N-WASP is
involved in regulating the stability of G9a and GLP (Fig. 8c, d).
This was conﬁrmed by analysis of the protein degradation
kinetic in the presence of cycloheximide, which revealed an
accelerated degradation of G9a and GLP in the absence of
N-WASP (Fig. 8e).
N-WASP is associated with chromatin-bound G9a and GLP.
Based on these results we tried to rescue the H3K9 methylation
defect by treating N-WASP-null keratinocytes with the protea-
some inhibitor MG-132. In addition, we assessed whether loss of
N-WASP affects chromatin binding of G9a and GLP, hypothe-
sizing that methyltransferases not attached to chromatin have a
reduced half-life. To this end, keratinocytes were fractionated into
a soluble cytoplasmic (C; marker: glyceraldehyde 3-phosphate
dehydrogenase (GAPDH)), a soluble nuclear (SN; marker: pro-
liferating cell nuclear antigen (PCNA)), and a pellet fraction
containing chromatin (P; marker: H3). N-WASP protein was
found in the cytoplasmic (65% ± 4%; n: 3) and in the chromatin
Fig. 6 IL-23A expression is increased in N-WASP-null keratinocytes. a qRT-PCR analysis of indicated genes in FACS puriﬁed primary keratinocytes from 6-
week-old mice (n: 4/4/4, mean ± SD, two-tailed unpaired t-test, 2 independent sorting). b qRT-PCR analysis of indicated cytokine mRNA expression in
primary keratinocytes. All normalized to GAPDH (n: 3/3, mean ± SD, two-tailed unpaired t-test). c Primary keratinocytes were differentiated with 2mM
CaCl2 (High Ca2+) for 48 h and then analyzed by qRT-PCR for IL-23A expression, compared to untreated cells (Low Ca2+; n: 3/3, mean ± SD, two-tailed
unpaired t-test). d qRT-PCR analysis of IL-23A mRNA expression in primary keratinocytes in response to 24 h treatment with indicated inhibitors. All
normalized to GAPDH (n: 3/3, mean ± SD, two-tailed unpaired t-test). e Representative immunoﬂuorescence of phalloidin in con and ko back skin. Scale
bar: 100 µm. f Quantiﬁcation of FACS mean ﬂuorescence intensity of phalloidin in con and ko primary keratinocyte (n: 3/3, mean ± SD, two-tailed unpaired
t-test). g qRT-PCR analysis of IL-23A mRNA expression in primary keratinocytes treated with indicated inhibitors for 24 h. All normalized to GAPDH. The
right panel shows the same data, but normalized to the respective DMSO-treated samples, thus showing the relative effect of the treatment as fold change
(n: 3/3, mean ± SD, two-tailed unpaired t-test; *p≤ 0.05; **p≤ 0.01; ***p≤ 0.001; ****p≤ 0.0001)
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03704-z
10 NATURE COMMUNICATIONS |  (2018) 9:1420 | DOI: 10.1038/s41467-018-03704-z | www.nature.com/naturecommunications
fraction (33% ± 2%), while the soluble nuclear fraction contained
only low amounts (2% ± 0.5%) (Fig. 8f).
Treatment of control and ko cells with MG-132 increased the
apparent molecular weight of G9a and GLP, which might reﬂect
ubiquitination of the proteins (Fig. 8f). In addition, protein
amounts of G9a and GLP in N-WASP ko keratinocytes treated
with MG-132 increased, corresponding to normal levels of
H3K9me2. Moreover, MG-132 also increased the protein level
of N-WASP in the soluble nuclear and the chromatin fraction,
but not in the cytosol, indicating that nuclear N-WASP is more
prone to proteasomal degradation (Fig. 8f). G9a and GLP were
nearly exclusively found in the chromatin pellet fraction and loss
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Fig. 8 N-WASP co-precipitates with and regulates the stability of the H3K9 methyltransferases G9a and GLP. Expression of G9a and GLP mRNA (a, b) and
protein (c, d) in epidermis of 6-day-old mice (a, c) and in primary keratinocytes (b, d). (n (a, b, c): 3/3; n (d): 5/5). e immunoblot analysis of protein
stability of G9a and GLP in primary keratinocytes in the presence of cycloheximide (G9a n: 4/4, GLP n: 6/6, mean ± SD, two-tailed unpaired t-test). f Cell
fractionation of keratinocytes after 90min of treatment with the proteasome inhibitor MG-132 followed by immunoblot for indicated proteins, the indicated
protein levels were quantiﬁed on the right (n: 3/3, mean ± SD, two-tailed unpaired t-test). g Cell fractionation of primary keratinocytes with treatment of
the pellet fraction with micrococcal nuclease followed by immunoblot for indicated proteins (MNase) (n: 3). h Co-precipitation of N-WASP with G9a and
GLP in primary keratinocyte nuclear lysates (n: 3). C: cytosolic fraction, SN: soluble nuclear fraction, P: pallet (*p≤ 0.05; **p≤ 0.01; ***p≤ 0.001)
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of N-WASP did not increase G9a and GLP levels detected in the
soluble nuclear fraction, indicating that N-WASP is not required
for the chromatin association of the methyltransferases.
To conﬁrm that N-WASP is indeed bound to chromatin and
not to insoluble cytoskeleton, we repeated the fractionation, but
digested chromatin with micrococcal nuclease (Fig. 8g). This
treatment increased the amount of N-WASP, G9a, GLP, H3, and
PCNA in the soluble nuclear fraction, indicating that N-WASP is
strongly associated with chromatin, similar to G9a and GLP.
We then tested whether N-WASP is forming a complex with
G9a and GLP. Indeed, N-WASP co-immunoprecipitated with
both H3K9 dimethyltransferases (Fig. 8h). Reciprocally, G9a
immunoprecipitated together with GLP and N-WASP. Control
precipitation with IgG did not result in detectable amounts of
G9a, GLP, or N-WASP. These data suggest the possibility that
direct or indirect association of N-WASP with chromatin-bound
G9a-GLP heterodimers is preventing the degradation of the
methyltransferases.
TNF regulates IL-23 expression via H3K9 methylation. In
psoriasis, TNF is an important activator of IL-23 expression27.
We therefore speculated that TNF is able to induce IL-23A
expression in keratinocytes and that this is mediated by N-
WASP-dependent changes in H3K9 dimethylation (H3K9me2).
To test this hypothesis, we stimulated both control and N-
WASP-null keratinocytes with TNF and checked IL-23A
expression after 4 h by qRT-PCR. While TNF treatment of
control cells increased IL-23A expression to a level comparable to
N-WASP-deﬁcient keratinocytes, it only slightly increased
expression in N-WASP-null cells (Fig. 9a). Normalizing the
values for TNF-treated cells by the respective values for untreated
cells showed that N-WASP-null keratinocytes are hardly
responding to TNF with respect to IL-23A expression, suggesting
that TNF and N-WASP regulate IL-23A expression by the same
pathway.
To examine whether this effect is caused by an increased TNF
signaling in N-WASP-null cells, we tested surface levels of TNF-
RI and activation of several TNF effectors in N-WASP-null and
control keratinocytes. However, FACS analysis did not reveal a
signiﬁcant change of TNF-RI at the cell membrane (Fig. 9b).
Furthermore, TNF induced phosphorylation of the TNF effector
molecules p38, c-Jun N-terminal kinase (JNK), and NF-κB was
unchanged in N-WASP ko cells compared to control keratino-
cytes (Fig. 9c).
We then checked how treatment with TNF is affecting protein
levels of G9a and GLP and H3K9 dimethylation in control and N-
WASP-null keratinocytes. In control keratinocytes, TNF resulted
in a dose-dependent decrease of G9a, GLP, and H3K9me2 levels
already after 10 min (Fig. 9c). H3K9me2 slowly increased
thereafter, while G9a and GLP remained also after 4 h at a low
level. N-WASP-null keratinocytes displayed low amounts of G9a,
GLP, and H3K9 dimethylation, which did not decrease further
after treatment with TNF, further supporting that TNF and N-
WASP work along the same pathway (Fig. 9c).
TNF induces phosphorylation of N-WASP. If N-WASP is acting
downstream of TNF, how is TNF signaling modifying nuclear N-
WASP function? TNF activates different serine/threonine kinases
as for example PKCα or IKKα. N-WASP, on the other hand, was
shown to be phosphorylated by casein kinase II at serine 480/481,
which decreases N-WASP-dependent actin polymerization14.
Therefore, we speculated that TNF-induced serine kinase acti-
vation might lead to phosphorylation of N-WASP at serine 480/
481 affecting the nuclear function of N-WASP. To investigate
this, we fractionated keratinocytes 10 min after treatment with
TNF. The chromatin fraction was extracted with a 300 mM NaCl
buffer to elute weakly chromatin-associated proteins. Treatment
with TNF resulted in a shift of nuclear N-WASP from the
strongly chromatin-bound fraction (Fig. 9d; P300) to the weakly
chromatin-bound fraction (S300). Interestingly, within the time
frame of the experiment, no signiﬁcant increase of N-WASP was
observed in the cytoplasmic fraction (C). Clearly, TNF stimula-
tion reduced chromatin association of N-WASP.
Moreover, TNF increased phosphorylation of N-WASP at
serine 480/481 (Fig. 6d). Phosphorylated N-WASP was found in
the cytoplasmic (C) and the weakly associated chromatin fraction
(S300), but not in the strongly associated nuclear fraction (P300).
These data suggest that phosphorylation of N-WASP at serine
480/481 is incompatible with strong chromatin binding. Since our
previous experiments demonstrated an increased proteolytic
degradation of G9a-GLP heterodimers in the absence of N-
WASP, the decreased chromatin attachment of phosphorylated
N-WASP might be associated with a dissociation of N-WASP
from the G9a-GLP heterodimers, resulting in increased degrada-
tion of the H3K9 methyltransferases.
Indeed, in a ChIP experiment, TNF treatment for 10 min
resulted in a decreased H3K9me2 of the IL-23A promoter in the
same region (B) as loss of N-WASP decreased H3K9me2 (Fig. 9e).
IOX-1 treatment of N-WASP ko keratinocytes rescued
H3K9me2 and IL-23A expression (Figs. 6g and 7b), but it did
not restore the ability of TNF to increase IL-23A expression
(Fig. 9f). This inability corresponds to the unchanged levels of
G9a, GLP, and H3K9me2 in TNF-treated N-WASP ko keratino-
cytes, suggesting that the N-WASP/G9a/GLP/H3K9me2 pathway
is crucial for the stimulation of IL-23A expression by TNF.
Collectively, these data indicate that regulation of H3K9me2 by
N-WASP is crucial for TNF-induced IL-23A expression in
keratinocytes in mice.
H3K9me2 is regulating IL-23 expression in human keratino-
cytes. Since our previous data indicated an important role for
H3K9 methylation for the regulation of IL-23A expression in
mouse keratinocytes, we wanted to test whether this mechanism
is also relevant in human keratinocytes and in psoriasis, an IL-23-
dependent chronic skin inﬂammation.
Treatment of primary human keratinocytes for 30 min with
TNF signiﬁcantly decreased G9a and H3K9me2 levels, while it
increased NF-κB phosphorylation (Supplementary Figure 3e).
Treatment with the G9a/GLP inhibitor BIX for 24 h decreased
H3K9me2 levels and increased IL-23A expression in a
concentration-dependent manner (Supplementary Figure 3a).
On the other hand, H3K9me2 levels were increased and IL-23A
mRNA levels decreased by incubation for 24 h with the histone-
demethylase inhibitor IOX-1 (Supplementary Figure 3c). Impor-
tantly, TNF-induced IL-23A expression was completely blocked
by pretreatment for 24 h with IOX-1, while BIX pretreatment
increased TNF-induced IL-23A expression (Supplementary
Figure 3b, d).
These data demonstrate that in human keratinocytes
H3K9me2 levels are also crucially important for regulating basal
and TNF-induced IL-23A expression.
Furthermore, we stained three sections of lesional and non-
lesional skin from three psoriasis patients for H3K9me2.
Compared to skin from healthy donors, skin from psoriasis
patients showed increased proliferation (Ki67; Fig. 10a). While
non-lesional epidermis showed a relatively uniform nuclear
staining of H3K9me2, H3K9me2 was decreased by about 50%
in psoriatic lesions, particularly in the suprabasal region (Fig. 10a,
c). Interestingly, skin of healthy controls stained in parallel
presented two-fold higher amounts of H3K9me2 than non-
lesional skin of psoriasis patients. Co-staining for IL-23p19
revealed an inverse correlation of H3K9me2 and IL-23 as
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expression of IL-23p19 was increased in H3K9me2 low
suprabasal regions of psoriatic lesions (Fig. 10b, c; Supplementary
Figure 2b).
These correlative ﬁndings support a role of H3K9me2
in the regulation of IL-23 expression in keratinocytes in
psoriasis.
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Discussion
The TNF/IL-23/IL-17 cytokine cascade is suggested to be
important for different inﬂammatory diseases. In psoriasis,
inhibitors against these cytokines are already used in the therapy
of this chronic skin inﬂammation2,3. Here we show in a mouse
model that keratinocytes can produce IL-23 at levels sufﬁcient to
cause differentiation of IL-17A-producing T cells and skin
inﬂammation. We furthermore describe a TNF/N-WASP/G9a,
GLP/H3K9me2 pathway that crucially regulates IL-23 expression
in human and mouse keratinocytes (Supplementary Figure 3F).
Since DNA damage response leads to decreased G9a levels28, and
polyinosinic:polycytidylic acid-induced Toll-like receptor signal-
ing decreases H3K9 methylation and increases IL-23 expression
in dendritic cells29, other signaling pathways might also converge
on this epigenetic control of IL-23 production in keratinocytes.
As IL-23 is conceived to be also important in other inﬂam-
matory diseases such as AD30 or SLE31, epigenetic regulation of
IL-23 expression in non-immune cells could also play a role in
these illnesses. Indeed, antibodies against dsDNA observed in the
serum of N-WASP ko mice are well known in SLE, but not in
psoriasis.
In conclusion, we report here a nuclear mechanism for TNF/
N-WASP-dependent epigenetic regulation of IL-23 that could
explain how environmental stress affects IL-23 expression, thus
contributing to chronic inﬂammatory diseases dependent on the
IL-23/IL-17 axis.
For Supplementary Discussion see Supplementary
Information.
Methods
Mice. Mice with keratinocyte-restricted deletion of the N-WASP gene (N-WASP ﬂ/
ﬂ K5 cre) were 129Sv/C56Bl6 outbred. The control mice used in all experiments are
either N-WASP ﬂ/ﬂ or ﬂ/+K5 cre (heterozygous ko), as we did not observe a
difference between these two genotypes. In all experiments, age- and gender-
matched litter mates were used as controls.
Mice with keratinocyte-restricted deletion of the IL23A gene were produced by
CRISPR-Cas9-mediated insertion of loxP sites upstream of exon 2 and downstream
of exon 4. Two single-guide RNAs (sgRNAs) were designed to target intron 1 and
4, respectively. Insertion of loxp sites was facilitated by 60 bp homologous arms
identical to the genomic sequences ﬂanking the cut sites (for sgRNA primers and
homologous arms see Supplementary Table 2). The resulting mutant mice were
than mated with N-WASP ﬂ/ﬂ K5 mice to generate mice with keratinocytes-
restricted deletion of both N-WASP and IL-23a genes (dko).
Mice with keratinocyte-restricted deletion of the G9a gene were generated by
crossing G9a ﬂ/ﬂ mice with K14-Cre mice (purchased from The Jackson
Laboratory, USA), resulting in G9a conditional KO mice.
All mice were kept in an AAALAC (Association for Assessment and
Accreditation of Laboratory Animal Care)-accredited animal house under speciﬁc
pathogen-free conditions. Licenses for breeding and experimentation were
obtained from the Danish Administration for Animal Experiments.
Barrier assay. To perform barrier assay, mouse E15.5 embryos, 2- and 6-day pups
were killed and rinsed in phosphate-buffered saline (PBS), and then immersed in
25, 50, 75 100, 75, 50, and 25% ice-cold methanol for 2 min each. Subsequently,
embryos and pups were immersed in 0.1% toluidine blue for 10 min on ice,
afterwards washed in PBS and photographed.
Cell isolation, culture and in vitro knockout. Primary keratinocytes were isolated
from skin adult mice by digestion with 0.8% trypsin in PBS for 30 min at 37 °C.
Keratinocytes were cultured in minimum essential medium Eagle with 5 mg l−1
insulin (Sigma #I5500), 10 μg l−1 EGF (Sigma #E9644), 10 mg l−1 transferrin
(Sigma #T8158), 10 μM phosphoethanolamine (Sigma #P0503), 10 μM ethanola-
mine (Sigma #E0135), 0.36 μg l−1 hydrocortisone (Calbiochem #386698), 1×
GlutaMAX (Invitrogen #35050), 1× penicillin/streptomycin (Invitrogen #15140),
and 40 ml of chelated fetal calf serum32. Normal human primary keratinocytes
were cultured in Lonza KGM-2 BulletKit (CC-3107, Lonza, Swiss).
To introduce in vitro recombination, HEK293T cells (ATCC CRL-3216) were
transfected with pRRLsin-GFP or pRRLsin-Cre-GFP plasmid together with pVSVg,
pPAX-2. Next day, HEK293T were cultured in keratinocytes medium for 48 h to
collect virus. Primary keratinocytes with ﬂ/ﬂ genotype were transduced with either
green ﬂuorescent protein (GFP) or Cre-GFP transducing virus for 48 h and
analyzed after 5–7 days in culture.
Inhibitor experiments. For inhibitor experiments primary keratinocytes isolated
from con and ko mice were treated for 24 h with 2 µM BIX01294 (3364, Tocris
UK), 2 µM HC (Tranylcypromine hydrochloride; 3852, Tocris UK), 200 µM IOX-1
(4464, Tocris UK), 0.1 µM TSA (1406, Tocris UK), 50 µM CK548 (C7499, Sigma,
USA), 0.5 µM latrunculin A (L5163, Sigma, USA), 10 µM MG-132 (1748, Tocris,
UK), or DMSO (Sigma, USA). For TNFα stimulation, keratinocytes were treated
with 10 ng ml−1 mouse TNFα (GF027, Millipore, USA) or as indicated in the
legend for indicated times. For TNFα and IOX-1 experiment, keratinocytes were
pretreated with 200 µM IOX-1 for 24 h and then followed by 4 h of TNFα sti-
mulation. To prevent protein synthesis, primary keratinocytes were treated with 20
µg ml−1 cycloheximide (46401, Sigma, USA) for indicated times. Normal human
primary keratinocytes were treated as indicated in the legend.
Subcellular fractionation. Fractionation of primary keratinocytes was done as
previously described33,34. Brieﬂy, keratinocytes were collected by scraping, resus-
pened in buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34M
sucrose, 10% glycerol, 1 mM dithiothreitol (DTT), 0.1% Triton X-100, protease and
phosphatase inhibitors) for 10 min on ice, and centrifuged for 5 min at 1300 × g.
The supernatant was cleared by centrifuging and collected as cytosol fraction (C).
The pellet was the resuspended in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM
DTT, protease and phosphatase inhibitors) on ice for 30 min, and centrifuged for 5
min at 1800 × g. The supernatant was collect as soluble nuclear fraction (S), and the
pellet was directly lysed as chromatin-enriched fraction (P). Alternatively, the pellet
fraction was further extracted with buffer C (20 mM HEPES-KOH, 1.5 mM MgCl2,
300 mM NaCl, 1 mM DTT, 0.2 mM EDTA, 20% (V/V) glycerol, pH 7.9) instead of
buffer B for 30 min, and then centrifuged for 5 min at 1800 × g. The supernatant
was collected as loose chromatin binding fraction (S300) and pellet as strong
chromatin binding fraction (P300).
For micrococcal nuclease digestion, the pellet fraction was resuspended in
buffer A with addition of 1 mM Cacl2 and 2 Uml−1 MNuclease (N5386, Sigma,
USA) for 2 min at 37 °C. The sample was then centrifuged for 5 min at 1800 × g.
The supernatant and pellet were collected and analyzed.
Flow cytometry. Preparative and analytical FACS was carried out according to
standard protocols. For preparative FACS sorting, single-cell suspensions were
prepared from epidermis32, blocked by rat anti-CD16/32 (14-0161, eBiosciences,
USA, 1:100 dilution) for 10 min on ice, and then stained with CD49f-FITC
(555735, BD Pharmingen, USA, 1:100 dilution) and CD45.2-PE (12-0454,
eBioscience, USA, 1:100 dilution) antibodies for 20 min on ice in dark. Samples
were then sorted by FACSaria Cell sorter (BD Biosciences, USA). Sorted cells were
lysed directly for RNA analysis.
Single-cell suspension from thymus, spleen, and bone marrow were stained with
CD3ε-CY5.5 (100328, all from BioLegend, USA, 1:100 dilution), CD4-FITC (11-
0041, 1:100 dilution), and CD8a-APC (17-0081, all from eBioscience, USA, 1:100
dilution).
For intracellular ﬂow cytometry, single-cell suspensions were derived from
epidermis as described above or from lymph nodes by pressing the tissue through a
Fig. 9 TNF regulates IL-23A expression by phosphorylating N-WASP and degradation of G9a/GLP complex. a qRT-PCR analysis of IL-23A mRNA
expression in con and ko primary keratinocytes treated for 4 h with TNFα (n: 3/3, mean ± SD, two-tailed unpaired t-test). b FACS analysis of surface TNF-RI
in primary keratinocytes (n: 3/3, two-tailed unpaired t-test). c Primary keratinocytes were treated for indicated times with TNFα and then tested by
immunoblot for expression of indicated proteins (n: 4/4). d Primary keratinocytes were treated for indicated time with TNF, fractionated, and analyzed by
immunoblot for indicated proteins (C: cytosolic fraction, S300: soluble nuclear fraction extracted by 300mM NaCl, P300: pellet after 300mM NaCl
extraction, SE: short exposure, LE: long exposure; n: 3). e ChIP of primary keratinocytes for H3K9me2 with qRT-PCR for indicated regions of IL-23A
promoter after treatment with TNFα for indicated times (n: 5/5, mean ± SD, two-tailed unpaired t-test). f qRT-PCR analysis of IL-23A mRNA expression in
con and ko primary keratinocytes pretreated with or without IOX-1 for 24 h and then stimulated with or without TNFα for 4 h as indicated. All normalized to
GAPDH (n: 4/4, mean ± SD, two-tailed unpaired t-test; *p≤ 0.05; **p≤ 0.01; ***p≤ 0.001)
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cell strainer (40 μm). To promote IL-17 expression and prevent secretion, cells were
ﬁrst stimulated for 6 h in RPMI containing cell stimulation cocktail plus protein
transport inhibitors (00-4975-93, eBioscience, USA) at 37 °C. The cell suspension
was then stained for surface markers for 20 min on ice in the dark, ﬁxed with 4%
paraformaldehyde for 10 min at room temperature, permeabilized with 0.1%
Triton X-100 on ice for 2 min, blocked with blocking buffer on ice for 10 min and
stained for intracellular markers. Data were collected by FACS Calibur (BD
Biosciences, USA) using the CellQuestPro software and analyzed by Flowjo 8.8.2.
The following antibodies were used: CD45.2-FITC (11-0454, 1:100 dilution), CD4-
FITC (11-0041, 1:100 dilution), TCRγ–FITC (11-5711, 1:100 dilution), IL-17a-APC
(17-7177-81, all eBioscience, USA, 1:100 dilution), TNFRI-PE (113003, 1:100
dilution), and CD3ε-CY5.5 (100328, 1:100 dilution, all BioLegend, USA).
ChIP. Chromatin Immunoprecipitation was done essentially as described in ref.
[35]. Primary keratinocytes isolated from con and ko mice skin were grown to an
approximate ﬁnal count of 5 × 107–1 × 108 cells for analysis. Cells were chemically
crosslinked with 1% formaldehyde solution for 10 min at room temperature with
gentle agitation and then quenched with 0.125 M glycine. Cells were rinsed three
times with 1× PBS. Cells were resuspended, lysed, and sonicated to solubilize and
shear crosslinked DNA. Sonication buffer (50 mM HEPES pH 7.5, 140 mM NaCl,
1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS, and 2 mM
PMSF, 1 μg ml−1 leupeptin, 1 μg ml−1 aprotinin). Bioruptor (Diagenode) was used
to ensure consistent sonication between samples. Sonication was performed for 4–6
cycles (30 s-ON, 30 s-OFF). The resulting chromatin extract was precleared and
appropriate amount was taken to incubate at 4 °C with 2–10 μg of H3K9me2 (4658,
all from Cell Signaling, USA) antibody overnight. Next morning, pre-blocked beads
were added and rotated for 3 h at 4 °C. Afterwards, beads were washed with
sonication buffer twice, washing buffer (2 mM Tris pH 8.0, 0.02 mM EDTA, 50
mM LiCl, 0.1% NP-40 0.1% Na-deoxycholate) once, TE buffer once, followed by
reverse crosslink for 5 h at 65 °C. DNA was then puriﬁed using the QIAGEN PCR
puriﬁcation kit according to the manufacturer’s protocol. H3K9me2 relative
occupancies were determined by calculating the immunoprecipitation efﬁciency
(ratios of the amount of immunoprecipitated DNA to that of the input sample).
Antibodies against H3K9me2 (4658, Cell Signaling, USA) were used for immu-
noprecipitation. Primers used for qRT-PCR of ChIP are listed in Supplementary
Table 2.
Gene expression analysis. RNA from skin and keratinocytes culture was prepared
using the GeneElute Mammalian Total RNA miniprep kit (RNT350, Sigma, USA)
according to the instructions of the manufacturer. Skin samples for RNA were ﬁrst
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Fig. 10 Decreased H3K9me2 in psoriatic lesions correlating with increased IL-23p19 expression. a, b H3K9me2 staining (a) and quantiﬁcation (b) in
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kept in RNA later (R0901, Sigma) until isolation. RNA was reverse transcribed to
complementary DNA (cDNA) by RevertAid H Minus First Strand cDNA Synthesis
Kit (K1632, Thermo Scientiﬁc, USA). qRT-PCR was performed on the Applied
Biosystems 7300 Real Time PCR system using SYBR green (K0221, Thermo Sci-
entiﬁc, USA) incorporation following standard protocols. The Ct value was cal-
culated based on duplicates and normalized to the housekeeping gene GAPDH.
Primers used for gene expression analysis are listed in Supplementary Table 2.
Microarray analysis was carried out at the Copenhagen University Hospital
Microarray Center. Total RNA samples were isolated from total back skin of 3 pairs
of 7-week-old control and mutant mice. RNA samples in each group were mixed at
equal amounts and transferred to the Copenhagen University Hospital Microarray
Center, where labeling of probes, hybridization to GeneChip MouseGene ST 1.0
(Affymetrix), and scanning of the arrays was carried out.
Immunoﬂuorescence and immunohistochemistry. Cryo and parafﬁn sections of
mice as well as primary keratinocytes cultured on glass slides were analyzed by
immunoﬂuorescent, immunohistochemical, and histochemical staining as descri-
bed previously18. Autoimmune antibodies in serum were detected by incubating
mouse keratinocytes with serum (1:100) and then with Cy-3-conjugated goat anti-
mouse. The following antibodies were used: CD45.2 (11-0454, eBioscience, USA,
1:100 dilution), Cre (15036S, Cell Signaling, 1:100 dilution), keratin 6 (PRB-169p,
Covance, USA, 1:400 dilution), H3K9me2 (4658, Cell Signaling, USA, or ab1220,
Abcam, UK, 1:200 dilution), IL-23p19 (LS-B573, LSBio, USA, 1:400 dilution), IL-
23p19 (511201, Biolegend, USA, 1:100 dilution), Ki67 (ab15580, Abcam, UK, 1:400
dilution), and CD49f-FITC (555735, BD Pharmingen, USA, 1:100 dilution). As
secondary reagent, 488- or Cy-3-conjugated goat anti-rabbit and goat anti-mouse
IgGs were used (both from Jackson ImmunoResearch, USA). Nuclear counter-
staining was performed with DAPI (4',6-diamidino-2-phenylindole; Sigma, USA).
Mast cells were stained with toluidine blue (89640, Sigma, USA) and F-actin with
Alexa Fluor 488 phalloidin (A12379, Invitrogen, USA, 1:400 dilution). Images were
analyzed with a Leica DM RXA2 confocal microscope, equipped with 20× HC PL
Apo (NA 0.70), 40× HCX PL APO (NA 1.25-0.75), and 63× HCX PL APO (NA
1.40-0.60) objectives and controlled by Leica Microsystems confocal software
(version 2.61 Build 1537; all from Leica Microsystems). ImageJ was used to
quantify ﬂuorescent images.
Human skin samples. Biopsies of healthy skin were obtained from 3 male donors
(ages 24, 46, and 51 years) and biopsies of lesional and corresponding non-lesional
skin were collected from 3 male patients with plaque psoriasis (ages 24, 25, and 57
years) under local ethical permissions and upon written informed consent. Cryo
sections of the human skin samples were prepared and stained as described above.
Biochemical analysis. Western blotting was performed according to standard
protocols. The following antibodies were used: pSmad2 (S465, S467) (3108S, 1:1000
dilution), H3K9me2 (4658, 1:4000 dilution), N-WASP (4848, 1:2000 dilution),
pSAPK/JNK (T183, Y185, 1:1000 dilution) (9251), pIRAK4 (T345, S346) (11927S,
1:1000 dilution), pNF-κB p65 (S536) (3033, 1:1000 dilution, all from Cell Signaling,
USA), G9a (3306, 1:500 dilution, Cell Signaling, USA, or 07-551, 1:500 dilution,
Millipore, USA), PCNA (ab29, 1:5000 dilution), β-actin (ac15, 1:10,000 dilution),
GLP (ab41969, 1:500 dilution all from Abcam, UK), Histone H3 (sc-8654, 1:2000
dilution), GAPDH (sc-25778, 1:5000 dilution), pp38 Thr180/Tyr182 (sc-17852,
1:2000 dilution, all from Santa Cruz, USA), and pN-WASP (S480, S481)
(MBS472040, 1:1000 dilution MyBioSource, USA).
As secondary agents, horseradish peroxidase (HRP)-coupled goat anti-rabbit,
goat anti-mouse, and donkey anti-goat antibodies were used (all from Jackson
ImmunoResearch, USA). All results were quantiﬁed using TotalLab
TL100 software (Nonlinear Dynamics). GAPDH, PCNA, β-actin, or Histone H3
was used for normalization.
Nuclear co-immunoprecipitation (co-IP) was done using the Nuclear Complex
Co-IP Kit (54001, Active Motif, USA) according to the manufacturer’s instruction.
A total of 50 μl Protein A agarose (16-125, Millipore) was used to pull down the
antibodies. Antibodies used for co-IP were N-WASP (4848, 1:50 dilution) and G9a
(3306, 1:50 dilution all from Cell Signaling, USA).
For co-IP of IL-23 heterodimer, the epidermal cells were lysed in RIPA buffer
for 30 min on ice and cleaned with Protein A agarose for 1 h at 4 °C. Rat anti-
mouse IL-23p19 (16-7232-81, Invitrogen, USA, 1:50 dilution) was added to the
cleaned lysate and precipitated by Protein A agarose. Rabbit anti-mouse IL-23p19
(NBP1-77257, Novus, USA, 1:1000 dilution) and rat anti-mouse IL-12p40 (505201,
BioLegend, USA, 1:100 dilution) were used for detection.
Uncropped scans of the most important blots are shown in Supplementary
Figure 4.
ELISA. Tissues protein lysates were obtained by using a Precellys® 24 bead-based
homogenizer (Precellys® Bertin Technologies, France) that allowed rapid protein
extraction of multiple samples. In brief, tissues were homogenized in cold 1× Cell
lysis buffer (Cell Signalling Technology, Danvers, MA, USA) containing a freshly
added protease inhibitor cocktail (Roche Applied Science, Penzberg, Germany) and
phosphatases inhibitor cocktail (Thermo Fischer Scientiﬁc, Walldorf, Germany),
followed by incubation in ice for 20 min to allow a complete lysis. Then, cell debris
was removed by centrifugation at 15,000 × g for 15 min at 4 °C and the
supernatants were transferred to a fresh microcentrifuge tube. Total protein con-
centration of all the samples was determined by BCA protein assay (Thermo
Fischer Scientiﬁc, USA). Ultimately, all samples were normalized to the same total
protein concentration of 2 mgml−1, prior analysis for the presence of the protein
of interest.
IL-1β, IL-12p70, and mKC were analyzed using the Th1/Th2 panel multiplex
kit from Meso Scale Discovery (MSD, Gaithersburg, MD, USA) and read on a
Sector Imager 6000 (MSD). IL-17F was analyzed using ELISA kit from R&D (R&D
Systems, Abingdon, UK). All assays were used following the instruction of the
manufacturer.
For anti-dsDNA ELISA, 100 μl of 5 μg ml−1 dsDNA isolated from mouse tail
was bound to microtiter plate at 4 °C overnight. The plate was blocked with 1%
bovine serum albumin (BSA) in PBS for 90 min, then incubated with 1% BSA in
PBS (negative control), anti-dsDNA antibody (1:200; MAB1293, Milipore, USA;
positive control), and sera from con and ko mice (1:200) for 1 h. Sera and
antibodies were diluted in 1% BSA in PBS. After washing three times with 0.1%
Tween-20 (Sigma) in PBS (PBST), the plate was incubated with anti-mouse IgG
HRP secondary antibody (1:1000; Jackson Immunoresearch) for 1 h and afterwards
washed three times with PBST. Plate-bound anti-dsDNA antibodies were detected
by 100 μl 3’,3’,5’,5’-tetramethyl benzidine substrate solution (T4444, Sigma-
Aldrich). The reaction was then transferred to a new plate and read at 650 nm on a
microplate reader (Glomax-multi+ detection system, Promega).
Statistics. Data are presented as means with error bars representing standard
deviation (SD). Statistical signiﬁcance was determined either by the two-tailed
Student’s t-test, or by one-way analysis of variance (ANOVA), with Tukey’s
multiple comparisons if not stated otherwise. Signiﬁcant differences are indicated
by asterisks (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001).
Data availability. Microarray data are available at ArrayExpress with accession ID
E-MTAB-6580 (https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6580/).
All other data are available from the corresponding author upon request.
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